Cas:155322-93-3 (3S,8aS)-Octahydropyrrolo[1,2-a]pyrazin-3-ylmethanol manufacturer & supplier

Chemical Name:(3S,8aS)-Octahydropyrrolo[1,2-a]pyrazin-3-ylmethanol

CAS.NO:155322-93-3

Synonyms:(2S,5S)-2-hydroxymethyl-1,4-diaza[4.3.0]bicyclononane;(2S,5S)-2-amino-N,N-dibenzylamino-4-oxo-1,6-diphenylhexane;3-Hexanone,5-amino-2-[bis(phenylmethyl)amino]-1,6-diphenyl-,(2S,5S);(2S,5S)-5-amino-2-dibenzylamino-3-oxo-1,6-diphenylhexane

Molecular Formula:C₈H₁₆N₂O

Molecular Weight:156.22500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:35.50000

Exact Mass:156.12600

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (2S,5S)-2-hydroxymethyl-1,4-diaza[4.3.0]bicyclononane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S,5S)-5-amino-2-dibenzylamino-3-oxo-1,6-diphenylhexane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2S,5S)-2-hydroxymethyl-1,4-diaza[4.3.0]bicyclononane Use and application,(2S,5S)-2-amino-N,N-dibenzylamino-4-oxo-1,6-diphenylhexane technical grade,usp/ep/jp grade.

Related News: With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. (3S,8aS)-Octahydropyrrolo[1,2-a]pyrazin-3-ylmethanol manufacturer In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. (3S,8aS)-Octahydropyrrolo[1,2-a]pyrazin-3-ylmethanol supplier The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. (3S,8aS)-Octahydropyrrolo[1,2-a]pyrazin-3-ylmethanol vendor In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. (3S,8aS)-Octahydropyrrolo[1,2-a]pyrazin-3-ylmethanol factory With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.